Calibrate
Metabolic reset with intensive coaching
Quick answer
Calibrate is an online metabolic reset with intensive coaching rated 3.9/5 by TeleRanked. It is cash-pay, with pricing from $1,649/yr.
Calibrate is a premium, year-long metabolic program combining GLP-1 medication with intensive coaching and insurance navigation.
- Starts at
- $1,649/yr
- Pricing
- Annual program
- Founded
- 2019
- HQ
- New York, NY
Insurance & cost
Cash price: $1,649/yr. Costs may be HSA/FSA eligible.
Public sentiment
3.3 / 5Trustpilot is high at 4.6, but a wave of refund complaints during the 2022-23 GLP-1 shortage and documented company instability (roughly 250 layoffs, then a distressed sale to lender Madryn in October 2023) pull the blend well below the star rating. The company continues to operate under new ownership.
Sharply more negative than Trustpilot: posts about undelivered medications, ghosted coaches, and unreachable support, plus layoffs, mass refunds, and a business restructuring.
Browse Reddit discussions →What Calibrate treats
Pros
- ✓Intensive year-long coaching
- ✓Clinical rigor
- ✓Insurance navigation help
Cons
- ✕High upfront annual cost
- ✕Long commitment
Verdict: Best for those wanting a structured, clinician-led year-long reset.
Visit Calibrate →Want the deep dive? Read our full Calibrate review →
Categories
Calibrate FAQ
Is Calibrate legit?+
Calibrate is a premium, year-long metabolic program combining GLP-1 medication with intensive coaching and insurance navigation. Calibrate connects patients with U.S.-licensed clinicians and is rated 3.9 out of 5 in our independent review.
Does Calibrate take insurance?+
No. Calibrate is cash-pay only and does not bill insurance. Pricing starts at $1,649/yr, and costs may be HSA or FSA eligible.
How much does Calibrate cost?+
Calibrate pricing starts at $1,649/yr (annual program).
What does Calibrate treat?+
Calibrate treats Weight loss (GLP-1), Metabolic health, Coaching.
What do reviews say about Calibrate?+
Trustpilot is high at 4.6, but a wave of refund complaints during the 2022-23 GLP-1 shortage and documented company instability (roughly 250 layoffs, then a distressed sale to lender Madryn in October 2023) pull the blend well below the star rating. The company continues to operate under new ownership. Trustpilot: 4.6/5 from ~1,000 reviews.
Is this your clinic? Claim your profile to manage these details, add media and link to your site. Claiming never affects your ranking.
Claim this profile →